Elsevier

Pathology

Volume 30, Issue 1, 1998, Pages 17-23
Pathology

Broadsheet number 42: Prostate specific antigen update

https://doi.org/10.1080/00313029800169615Get rights and content

First page preview

First page preview
Click to open first page preview
View PDF

References (93)

  • G.N. Collins et al.

    The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice

    J Urol

    (1997)
  • E.P. DeAntoni et al.

    Age-and race-specific reference ranges for prostate-specific antigen from a large community-based study

    Urology

    (1996)
  • S. Kamoshida et al.

    Extmprostatic localisation of prostatic acid phosphatase and prostate specific antigen: distribution in cloacogenic glandular epithelium and sex dependent expression in the human anal gland

    Hum Pathol

    (1990)
  • R.B. Watson et al.

    Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis

    Urology

    (1996)
  • R.S. Pruthi et al.

    Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation With histologic characteristics of the primary cancer

    Urology

    (1997)
  • H.C. Ruckle et al.

    Prostate specific antigen: concepts for staging prostate cancer and monitoring response to therapy

    Mayo Clin Proc

    (1994)
  • F.M. Chybowski et al.

    Predicting radionuclide bone scan finding in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters

    J Urol

    (1991)
  • M.S. Cookson et al.

    Prognostic significance of prostate-specific antigen in stage Tlc prostate cancer treated by radical prostatectomy

    Urology

    (1997)
  • A.W. Partin et al.

    The use of prostate specific antigen: clinical stage and gleason score to predict final pathological stage in men with prostate cancer

    J Urol

    (1993)
  • K. Pummer et al.

    False positive prostate specific antigen values in the sera of women with renal cell carcinoma

    J Urol

    (1992)
  • P.A. Humphrey et al.

    Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

    J Urol

    (1996)
  • S.E. Lerner et al.

    Prostate specific antigen detected prostate cancer (clinical stage Tlc): an interim analysis

    J Urol

    (1996)
  • C.A. Olsson et al.

    Detection and treatment of prostate cancer: perspective of the urologist?

    J Urol

    (1994)
  • T.D. Richardson et al.

    Age-specific reference ranges for serum prostate-specific autigen

    Urol Clin North Am

    (1997)
  • A.W. Partin et al.

    Prostate specific antigen in the staging of localised prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

    J Urol

    (1990)
  • W.J. Catalona et al.

    Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves

    J Urol

    (1994)
  • J. Morote et al.

    Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng/ml

    J Urol

    (1997)
  • C.H. Bangma et al.

    The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

    Urology

    (1995)
  • H.B. Carter et al.

    Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

    J Urol

    (1997)
  • A.B. Gutman et al.

    An ‘acid’ phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland

    J Clin Invest

    (1938)
  • M. Hara et al.

    Preparation and immunoetectric assessment of antisera to human seminal plasma

    Jpn J Leg Med

    (1966)
  • L.D. Papsidero et al.

    A prostate antigen in the sera of prostatic cancer patients

    Cancer Res

    (1980)
  • G.F. Sensabaugh

    Isolation and characterisation of a semen-specific protein from human seminal plasma: a potential new marker for semen identification

    J Forensic Sci

    (1978)
  • H. Lilja

    A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

    J Clin Lab Invest

    (1985)
  • P.H.J. Reigman et al.

    Characterisation of the human kallikrein locus

    Genomics

    (1992)
  • T.K. Takayama et al.

    Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein

    J Biol Chem

    (1997)
  • A. Christensson et al.

    Enzymatic activity of the prostate specific antigen and its reactions with extracellular serine protease inhibitors

    Ear J Biochem

    (1990)
  • L. Sottrup-Jensen

    Alpha-macroglobulins: structure, shape and mechanism of proteinase complex formation

    J Biol Chem

    (1989)
  • J. Gleimann et al.

    Cell association and degradation of alpha 2-macrogtobulin-trypsin complexes in hepatocytes and adipocytes

    Biochim Biophys Acta

    (1983)
  • H. Lilja et al.

    Prostate-specific antigen in serum occurs predominantly in complex with alpha-l-antichymotrypsin

    Clin Chem

    (1991)
  • M. Brawer

    Personal communication,

    (1997)
  • A. Belanger et al.

    Molecular mass and carbohydrate structure of prostate specific antigen studies for establishment of an international PSA standard

    Prostate

    (1995)
  • Z. Chen et al.

    Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays

    Clin Chem

    (1995)
  • T.A. Stamey et al.

    Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

    New Eng J Med

    (1987)
  • J.P. Van Straalen et al.

    Biological half life of prostate specific antigen after radical prostatectomy

    Eur J Clin Chem Clin Biochem

    (1994)
  • M.C. Wang et al.

    Purification of a human prostate specific antigen

    Invest Urol

    (1979)
    • View full text
    Copyright © 1998 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.